Role of p38 MAP Kinase in Regulation of Cell Migration and Proliferation in Healing Corneal Epithelium

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 1, 2004, Pages 100-109

  Saika, Shizuya ^a   Okada, Yuka ^a   Miyamoto, Takeshi ^a   Yamanaka, Osamu ^a   Ohnishi, Yoshitaka ^a   Ooshima, Akira ^a   Liu, Chia Yang ^b   Weng, Daniel ^c   Kao, Winston W Y ^c  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; DEBRIDEMENT; ENZYME ACTIVATION; ENZYME REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; WOUND HEALING;

ANIMALS; CELL DIVISION; CELL MOVEMENT; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EPITHELIUM, CORNEAL; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASES; ORGAN CULTURE TECHNIQUES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 0346727570     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0700     Document Type: Article

References (51)

1. Katakami C, Perkins T, Dorfman N, Spaulding AG, Kao WW-Y. Polymorphonuclear leukocytes inhibit proliferation of epithelial cells in rabbit cornea (in Japanese). Nippon Ganka Gakkai Zasshi (Acta Soc Ophthalmol Jpn). 1988;92:798-805.
2. Lu L, Reinach PS, Kao WW-Y. Corneal epithelial wound healing. Exp Biol Med (Maywood). 2001;226:653-664.
3. Schultz G, Rotatori DS, Clark W. EGF and TGF-α in wound healing and repair. J Cell Biochem. 1991;45:346-352.
4. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
5. Wilson SE, Chen L, Mohan RR, Liang Q, Liu J. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res. 1999;68:377-397.
6. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18:293-309.
7. Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J. 1999;13:2105-2124.
8. Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000;57:2207-2214.
9. Dunker N, Krieglstein K. Targeted mutations of transforming growth factor-β genes reveal important roles in mouse development and adult homeostasis. Eur J Biochem. 2000;267:6982-6988.
10. Li DQ, Tseng SC. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-alpha, platelet-derived growth factor B, and interleukin-1beta. Invest Ophthalmol Vis Sci. 1996;37:2068-2080.
11. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol. 1991;115:1091-1105.
12. Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61-79.
13. Wilson SE, Schultz GS, Chegini N, Weng J, He YG. Epidermal growth factor, transforming growth factor α, transforming growth factor β, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994;59:63-71.
14. Nishida K, Sotozono C, Adachi W, Yamamoto S, Yokoi N, Kinoshita S. Transforming growth factor-β1, -β2 and -β3 mRNA expression in human cornea. Curr Eye Res. 1995;14:235-241.
15. Joyce NC, Zieske JD. Transforming growth factor-β receptor expression in human cornea. Invest Ophthalmol Vis Sci. 1997;38:1922-1928.
16. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-β responses. Cell. 1998;95:737-740.
17. Massague J. How cells read TGF-β signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
18. Zhu HJ, Burgess AW. Regulation of transforming growth factor-β signaling. Mol Cell Biol Res Commun. 2001;4:321-330.
19. Mita T, Yamashita H, Kaji Y, et al. Effects of transforming growth factor β on corneal epithelial and stromal cell function in a rat wound healing model after excimer laser keratectomy. Graefes Arch Clin Exp Ophthalmol. 1998;236:834-843.
20. Zieske JD, Hutcheon AEK, Guo X, Chung EH, Joyce NC. TGF-β receptor types I and II are differentially expressed during corneal epithelial wound repair. Invest Ophthalmol Vis Sci. 2001;42:1465-1471.
21. Saika S, Shiraishi A, Saika S, et al. Role of lumican in the corneal epithelium during wound healing. J Biol Chem. 2000;275:2607-2612.
22. Lovicu FJ, Kao WW-Y, Overbeek PA. Ectopic gland induction by lens-specific expression of keratinocyte growth factor (FGF-7) in transgenic mice. Mech Dev. 1999;88:43-53.
23. Ishizaki M, Zhu G, Haseba T, Shafer SS, Kao WW-Y. Expression of collagen I, smooth muscle alpha-actin, and vimentin during the healing of alkali-burned and lacerated corneas. Invest Ophthalmol Vis Sci. 1993;34:3320-3328.
24. Klekotka PA, Santoro SA, Zutter MM. Alpha 2 Integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK. J Biol Chem. 2001;276:9503-9511.
25. Li W, Nadelman C, Henry G, et al. The p38-MAPK/SAPK pathway is required for human keratinocyte migration on dermal collagen. J Invest Dermatol. 2001;117:1601-1611.
26. Dumon N, Bakin AV, Arteaga CL. Autocrine transforming growth factor-β signaling mediates Smad independent motility in human cancer cells. J Biol Chem. 2003;278:3275-3285.
27. Vadlamudi R, Adam L, Talukder A, Mendelsohn J, Kumar R. Serine phosphorylation of paxillin by heregulin-β1: role of p38 mitogen activated protein kinase. Oncogene. 1999;18:7253-7264.
28. Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity. J Biol Chem. 2001;276:46707-46713.
29. Murakami-Mori K, Mori S, Nakamura S. p38MAP kinase is a negative regulator for ERK1/2-mediated growth of AIDS-associated Kaposi's sarcoma cells. Biochem Biophys Res Commun. 1999;264:676-682.
30. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem. 2001;268:6058-6065.
31. Matsumoto T, Turesson I, Book M, Gerwins P, Claesson-Welsh L. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol. 2002;156:149-160.
32. Yu Y, Sato JD. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol. 1999;178:235-246.
33. Cocolakis E, Lemay S, Ali S, Lebrun JJ. The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem. 2001;276:18430-18436.
34. Giehl K, Sedel B, Gierschik P, Adler G, Menke A. TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation. Oncogene. 2000;14:4531-4541.
35. Jono H, Xu H, Kai H, et al. Transforming growth factor-β-Smad signaling pathway negatively regulates nontypable Haemophilis influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK. J Biol Chem. 2003;278:27811-27819.
36. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol Cell Biol. 1999;19:2495-2504.
37. Lee S, Cho YS, Shim C, et al. Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervical carcinoma cell line. Int J Cancer. 2001;94:500-507.
38. ten Dijke P, Goumans M-J, Itoh F, Itih S. Regulation of cell proliferation by Smad proteins (review). J Cell Physiol. 2002;191:1-16.
39. Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol. 1999;1:260-266.
40. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J Biol Chem. 1999;274:8949-8957.
41. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 2001;12:27-36.
42. Wang W, Zhou G, Hu MC, Yao Z, Tan TH. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor β (TGF-β)-activated kinase (TAK1), a kinase mediator of TGF β signal transduction. J Biol Chem. 1997;272:22771-22775.
43. Engel ME, McDonnell MA, Law BK, Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem. 1999;274:37413-37420.
44. Petritsch C, Beug H, Balmain A, Oft M. TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev. 2000;14:3093-3101.
45. Gotzmann J, Huber H, Thallinger C, et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness. J Cell Sci. 2002;115:1189-1202.
46. Peron P, Rahmani M, Zagar Y, Durand-Schneider AM, Lardeux B, Bernuau D. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-β in rat hepatocytes role of phosphatidylinositol 3-kinase-induced AP-1 activation. J Biol Chem. 2001;276:10524-10531.
47. Weng J, Mohan RR, Li Q, Wilson SE. IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 β expression in the cornea. Cornea. 1997;16:465-471.
48. Saklatvala J, Dean J, Finch A. Protein kinase cascades in intracellular signalling by interleukin-1 and tumour necrosis factor. Biochem Soc Symp. 1999;64:63-77.
49. Sharma GD, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem. 2003;278:21989-21997.
50. Kim JY, Choi JA, Kim TH, et al. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J Cell Physiol. 2002;190:29-37.
51. McBain VA, Forrester JV, McCaig CD. HGF, MAPK, and a small physiological electric field interact during corneal epithelial cell migration. Invest Ophthalmol Vis Sci. 2003;44:540-547.